New: 2026 Peptide Research Digest is live. Read the report
Research-backed content PubMed cited sources Medically reviewed by experts Quarterly content updates Research-backed content PubMed cited sources Medically reviewed by experts Quarterly content updates Research-backed content PubMed cited sources Medically reviewed by experts Quarterly content updates Research-backed content PubMed cited sources Medically reviewed by experts Quarterly content updates Research-backed content PubMed cited sources Medically reviewed by experts Quarterly content updates Research-backed content PubMed cited sources Medically reviewed by experts Quarterly content updates Research-backed content PubMed cited sources Medically reviewed by experts Quarterly content updates Research-backed content PubMed cited sources Medically reviewed by experts Quarterly content updates

Semaglutide

Weight Loss

GLP-1 Receptor Agonist

Calculate Reconstitution Read Full Data Guide

Overview Profile

A GLP-1 receptor agonist that increases insulin secretion and decreases glucagon, widely researched and approved for weight management.

Primary Target Benefits

weight lossmetabolic healthblood sugar

Research Notice: This profile is informational. Peptides are widely sold as research chemicals and many are not FDA-approved for human consumption. Always consult local regulations and a medical provider before proceeding.

Quick Research Facts

Standard Dose Observation

250-2400 mcg

Typical Available Vial Sizes

2.5mg5mg10mg

Development / Research Status

FDA-Approved

More in Weight Loss

Tirzepatide

Dual GIP and GLP-1 Receptor Agonist

View Profile

AOD-9604

Advanced Obesity Drug 9604

View Profile

Retatrutide

Triple Agonist

View Profile